Triple Point Venture - ISSUE OF EQUITY AND TOTAL VOTING RIGHTS

Triple Point Venture VCT

16/02/2026 14:31

RNS Number : 2053T

Triple Point Venture VCT PLC

16 February 2026

 

16 February 2026

 

Triple Point Venture VCT Plc

(the "Company")

ISSUE OF EQUITY AND TOTAL VOTING RIGHTS

The Directors of Triple Point Venture VCT Plc (the "Company") are pleased to announce the allotment of 9,866,963 Venture Shares of 1p each at an average price of 94.638p pence per share on 16 February 2026 pursuant to the offer for subscription set out in a prospectus issued by the Company on 5 September 2025.

The shares allotted are to be admitted to the Official List. Admission is expected to become effective on or around 17 February 2026.

As a consequence of this allotment the issued share capital and total voting rights of the Company is now 119,889,748 Venture Class Shares.

 

FOR FURTHER INFORMATION ON THE COMPANY, PLEASE CONTACT:

Triple Point Investment Management LLP
(Investment Manager)
Tel: 020 7201 8989
Seb Wallace
Jack Rose


 

The Company's LEI is 213800AOOAQA5XQDEA89

 

Further information on the Company can be found on its website  https://www.triplepoint.co.uk/current-vcts/triple-point-venture-vct-plc/s2539/

NOTES:

The Company is a Venture Capital Trust incorporated in July 2010 and was established to fund small and medium sized enterprises. The Investment Manager is Triple Point Investment Management LLP.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
IOEEALAKFANKEFA